[Federal Register Volume 61, Number 221 (Thursday, November 14, 1996)]
[Notices]
[Page 58424]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-29118]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 18, 1996, Norac 
Company, Inc., 405 S. Motor Avenue, Azusa, California 91702, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the Schedule I controlled 
substance tetrahydrocannabinols (7370).
    The firm plans to manufacture medication for the treatment of AIDS 
wasting syndrome and as an antiemetic.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than January 13, 1997.

    Dated: October 21, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-29118 Filed 11-13-96; 8:45 am]
BILLING CODE 4410-09-M